Axogen, Inc. - Common Stock (NQ:AXGN)

49.27 +11.80 (+31.51%)

Delayed Quote Updated: 3:08 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axogen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Axogen Earnings Perspective: Return On Capital Employed ↗

March 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 14, 2023

Via Benzinga

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

March 14, 2023

From Axogen, Inc.

Via GlobeNewswire

A Preview Of Axogen's Earnings ↗

March 13, 2023

Via Benzinga

Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel

March 06, 2023

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

From Axogen, Inc.

Via GlobeNewswire

Read JMP Securities' Take On Axogen's Interim Update ↗

July 20, 2022

Via Benzinga

Axogen Aces Phase 3 Study For Avance Nerve Graft ↗

May 05, 2022

Via Benzinga

Axogen: Q4 Earnings Insights ↗

February 22, 2022

Axogen (NASDAQ:AXGN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen...

Via Benzinga

Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023

March 02, 2023

From Axogen, Inc.

Via GlobeNewswire

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

February 13, 2023

From Axogen, Inc.

Via GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

January 09, 2023

From Axogen, Inc.

Via GlobeNewswire

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

January 05, 2023

Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including...

From Axogen, Inc.

Via GlobeNewswire

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

January 04, 2023

From Axogen, Inc.

Via GlobeNewswire

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

December 19, 2022

From Axogen, Inc.

Via GlobeNewswire

Axogen, Inc Reports 2022 Third Quarter Financial Results

November 08, 2022

From Axogen, Inc.

Via GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

November 03, 2022

From Axogen, Inc.

Via GlobeNewswire

Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.

October 31, 2022

Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine.

From Axogen, Inc.

Via GlobeNewswire

Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022

October 20, 2022

From Axogen, Inc.

Via GlobeNewswire

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Axogen: Q2 Earnings Insights ↗

August 03, 2022

Axogen (NASDAQ:AXGN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022 ↗

May 09, 2022

Upgrades

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher ↗

May 05, 2022

U.S. stocks remained lower toward the end of trading, with the Nasdaq Composite dropping more than 650 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 05, 2022

Via Benzinga

83 Biggest Movers From Yesterday ↗

May 06, 2022

Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.

Via Benzinga

Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points ↗

May 05, 2022

U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday.

Via Benzinga

57 Stocks Moving In Thursday's Mid-Day Session ↗

May 05, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 04, 2022

Gainers 1Life Healthcare (NASDAQ:ONEM) shares moved upwards by 22.4% to $9.58 during Wednesday's after-market session. The market value of their outstanding shares is at $1.8 billion. The company's, Q1...

Via Benzinga

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗

May 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 01, 2022

Gainers Organogenesis Holdings (NASDAQ:ORGO

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.